𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chronic lymphocytic leukemia in association with a second lymphoproliferative disorder: Response to chemotherapy in two cases

✍ Scribed by Gordon, Leo I. ;Hrushesky, William ;Oken, Martin M. ;Kay, Neil E. ;Rydell, Robert E.


Publisher
John Wiley and Sons
Year
1979
Tongue
English
Weight
398 KB
Volume
7
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis


The development of either histiocytic lymphoma or Hodgkin disease in association with pre-existing chronic lymphocytic leukemia has been described in the literature as a terminal event. We describe two patients in whom the diagnosis of a second malignant lymphoma was made during life and who achieved objective clinical response after a change in therapy to a more aggressive combination of drugs. We conclude that patients with chronic lymphocytic leukemia who have had a sudden change in their clinical course should have thorough reevaluation, looking specifically for the development of a second lymphoproliferative disorder. If this is discovered, more aggressive therapy should be initiated.


πŸ“œ SIMILAR VOLUMES


Response of agranulocytosis to thymectom
✍ Weir, Alva B. ;Dow, Lois W. πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 343 KB

A patient with chronic lymphocytic leuke-Both autologous and heterologous granulomia presented with recurrent episodes of cyte macrophage colony growth were severe neutropenia. This neutropenia was clearly inhibited by the patient's serum. This initially responsive to prednisone but evenis the first

Transient response of pure red cell apla
✍ Dr. William Hocking; Richard Champlin; Ronald Mitsuyasu πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 484 KB πŸ‘ 3 views

Pure red cell aplasia (PRCA) is an unusual complication of chronic lymphoproliferative disorders. A patient with T-cell chronic lymphocytic leukemia (T-CLL) had severe anemia and neutropenia. Initial in vitro studies demonstrated no evidence of T-cell suppression of erythropoiesis. Sequential bone m

Transient response to imatinib in a chro
✍ Christoph Walz; Claire Curtis; Susanne Schnittger; Beate Schultheis; Georgia Met πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 210 KB

## Abstract Chronic myeloproliferative disorders with rearrangements of the platelet‐derived growth factor receptor A (__PDGFRA__) gene at chromosome band 4q12 have shown excellent responses to targeted therapy with imatinib. Here we report a female patient who presented with advanced phase of a ch